ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.71
-0.78%
US Tech 100
21,524.40
0.41%
S&P 500
6,114.63
-0.01%
US Dollar vs CAD
1.41865
-0.02%
Bitcoin
95,385.82
-0.77%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRON
DateTimeSourceHeadlineSymbolCompany
02/14/20256:50AMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRONDisc Medicine Inc
02/12/20255:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/12/20255:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/12/20258:08AMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRONDisc Medicine Inc
02/04/20254:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
01/24/20253:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
01/23/20254:24PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
01/22/20258:35PMGlobeNewswire Inc.Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:IRONDisc Medicine Inc
01/21/20254:24PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
01/21/20253:01PMGlobeNewswire Inc.Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:IRONDisc Medicine Inc
01/21/20256:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
01/21/20256:45AMGlobeNewswire Inc.Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA SubmissionNASDAQ:IRONDisc Medicine Inc
01/20/20256:00PMGlobeNewswire Inc.Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
01/17/20253:00PMGlobeNewswire Inc.Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)NASDAQ:IRONDisc Medicine Inc
01/10/20258:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
01/10/20258:00AMGlobeNewswire Inc.Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025NASDAQ:IRONDisc Medicine Inc
01/06/20254:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
01/02/20253:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
12/09/202411:00AMGlobeNewswire Inc.Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
12/09/20247:48AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
12/08/20247:00PMGlobeNewswire Inc.Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual MeetingNASDAQ:IRONDisc Medicine Inc
11/26/20247:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
11/25/20243:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
11/19/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRONDisc Medicine Inc
11/19/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
11/15/20243:47PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
11/15/20243:43PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IRONDisc Medicine Inc
11/15/20243:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
11/15/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
11/14/20244:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRONDisc Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:IRON

Your Recent History

NASDAQ
NFE
New Fortress Energy
DBI
4N9X
DAXsubsector All Securit...
BIT
UC1C02
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads